18 Articles with the topic: Pharma & Medical Industry News
Should healthy people take statins too?
sea-maid submitted, created time 4 days 10 hours (www.nature.com)
The results of a study examining whether a potent cholesterol-lowering drug decreases the risk of heart disease are out. Rosuvastatin was given to 17,802 seemingly healthy people, and their chance of developing heart problems plummeted. The results, published in the New England Journal of Medicine, have revealed a number of questions about how to prevent heart attacks. Is exercise and a low-fat diet enough, or should large swathes of the population be prescribed preventative medication? Nature News gets to the heart of the matter. 
Ginkgo Biloba Does Not Reduce Dementia Risk, Study Shows
piggy submitted, created time 2 days 2 hours (www.sciencedaily.com)
The medicinal herb Ginkgo biloba does not reduce the risk of dementia or Alzheimer's disease development in either the healthy elderly or those with mild cognitive impairment, according to a large multicenter trial led by researchers at the University of Pittsburgh School of Medicine.
Findings from the Ginkgo Evaluation of Memory (GEM) Study, which is the first to have the necessary participant numbers and monitoring years to enable measurement of G. biloba's effectiveness and safety profile in dementia prevention, were just published in the Journal of the American Medical Association
Ark floats gene therapy's boat, for now
sea-maid submitted, created time 3 weeks 5 days (www.nature.com)
In August, gene therapy's turbulent ride through the clinical rapids took a new twist as Ark Therapeutics released positive top-line results from a phase 3 trial of its adenoviral gene therapy Cerepro (sitimagene ceradenovec) for malignant brain tumors. Although the news boosted the London-based firm's shares, the course to market authorization and registration remains strewn with uncertainty—as Introgen, of Austin, Texas, found, to its cost, when the U.S
GlaxoSmithKline's customized "red wine" drug potent in mice
piggy submitted, created time 2 weeks 23 hours (www.reuters.com)
LONDON (Reuters) - A drug in development that mimics a health-boosting compound found in red wine may be a powerful weapon in the fight against obesity and diabetes, researchers said on Tuesday.
A study of mice showed that the GlaxoSmithKline drug SRT1720 was about a thousand times more potent than resveratrol in activating an enzyme that helped the animals burn more energy and lower their insulin and glucose levels
sea-maid submitted, created time 3 weeks 4 days (www.fiercebiotech.com)
Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) announced today that it has entered into a letter of intent for a business combination with Medigen Biotechnology Corp. ("Medigen"), a biotech company traded over the bulletin board in Taiwan. In connection with the transaction, Pacgen would acquire all of the issued and outstanding shares of Medigen by way of share purchase or through such other transaction structure as may be determined by the mutual agreement of Medigen and Pacgen
BioTie Therapies Inc. to Acquire Neurology and Immunology Focused Pharmaceutical Company Elbion GmbH
sea-maid submitted, created time 3 weeks 4 days (www.fiercebiotech.com)
BioTie Therapies has today entered into an agreement to acquire the German pharmaceutical company elbion GmbH. The combination of the two businesses will take place by a share exchange and create a leading European company in the field of discovery and development of therapeutics for central nervous system (addiction, psychotic disorders) and inflammatory diseases (e.g. rheumatoid arthritis, psoriasis and inflammatory diseseas of the respiratory system). elbion GmbH will become a wholly-owned subsidiary of BioTie.
HIV vaccine failure explained?
sea-maid submitted, created time 2 weeks 1 day (www.nature.com)
Researchers have suggested that an experimental vaccine against AIDS might have failed in part because it made some people's immune cells more vulnerable to HIV infection.
Pfizer ends development of obesity drug
piggy submitted, created time 2 weeks 4 hours (www.reuters.com)
NEW YORK, Nov 5 (Reuters) - Pfizer Inc on Wednesday became the latest drugmaker to abandon an obesity treatment that works by blocking the receptors in the brain that makes people hungry after smoking marijuana.
The world's largest drugmaker said it was terminating late stage development of its experimental obesity drug, CP-945,598, citing a more conservative regulatory climate and problems seen with other medicines from the same class
Industry shifts focus to immunology and cancer
sea-maid submitted, created time 1 week 3 days (www.nature.com)
Economic factors, including competition from generic drugs, is hitting even the big pharmaceutical companies hard, reports Nature. In 2010, Pfizer's Lipitor enters the public domain. For these reasons, the larger companies are narrowing the focus of their research, hitting fewer diseases. They're also working on fewer primary care drugs and more drugs that would be prescribed by specialists, such as cancer drugs.
"When Wyeth Pharmaceuticals announced last week that it would cut some of its research and development (R&D) programs in women's health, the decision seemed counterintuitive
Men who take aspirin have significantly lower PSA levels
sea-maid submitted, created time 3 days 23 hours (www.genengnews.com)
The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University.
Roche confirms Genentech bid, nine-month sales down 2%
sea-maid submitted, created time 4 weeks 2 days (www.reuters.com)
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG confirmed its commitment to a $43.7 billion bid for the rest of Genentech Inc and reported a two percent fall in nine-month sales to 33.3 billion Swiss francs ($29.26 billion).
Antibacterial drugs: New paths to beating bacteria
sea-maid submitted, created time 2 weeks 4 days (www.nature.com)
The need for new drugs to combat multidrug-resistant bacteria remains pressing. Now, two recent papers published in Science describe novel agents that target different mechanisms to currently approved antibacterials, which may help tackle this challenge.
The first study, by Haydon and colleagues, set out to target bacterial cell division. FtsZ is an essential bacterial protein that undergoes GTP-dependent polymerization to form the Z ring — the site of cell division — promoting the sequential recruitment of additional proteins that are vital to the process
Merck vaccine protects men from wart virus, too
sea-maid submitted, created time 1 week 1 day (www.reuters.com)
A vaccine designed to protect women and girls from cervical cancer caused by a wart virus may protect men, too, maker Merck and Co reported on Thursday
sea-maid submitted, created time 3 weeks 3 days (www.fiercebiotech.com)
VioQuest Pharmaceuticalstoday provided a strategic alternatives review and operations update.
Savient shares fall over gout drug safety concerns
sea-maid submitted, created time 3 weeks 3 days (biz.yahoo.com)
Shares of Savient Pharmaceuticals plunged Monday as Wall Street urged caution over the safety profile of the drug developer's candidate for gout treatment Puricase.
The stock plunged $8.51, or 73.5 percent, to $3.07. Earlier in the session, shares fell to $2.80, their lowest point in more than three years.
On Monday, Savient reported more late-stage study data on Puricase, reinforcing its effectiveness in prior results. If approved, the drug would be administered intravenously, with the goal of removing uric acid from the blood
abuse@discover8.com
angelfish
Darkfrog
kavin
Sue Wu
jane2007
DanyC
addict
T7
www.genscript.com
Myomodulin
Myomodulin is present in two identified aplysia neurons that ...
www.genscript.com
Adrenocorticotropic Hormone (ACTH) (1-24), human
Adrenocorticotropic hormones (ACTH). ACTH stimulates the adr ...
www.genscript.com
Cl-HOBt
For the rapid, single-step purification of glutathione S-tra ...
www.genscript.com